Related Experiment Video
Updated: Jun 21, 2025

10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.8K
TB among refugees from Ukraine in European countries
G de Vries1, J P Guthmann2, B Häcker3
1National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
IJTLD Open
|July 11, 2024
Summary
Tuberculosis (TB) rates among Ukrainian refugees were lower than expected but increased with screening. Host countries need robust TB services for tailored diagnosis and treatment, especially for multidrug-resistant TB.
Area of Science:
- Public Health
- Infectious Disease Epidemiology
- Migration Health
Background:
- Millions of refugees fled Ukraine following the Russian Federation's invasion.
- Assessing the tuberculosis (TB) burden in this displaced population is crucial.
- Understanding current TB screening approaches for refugees is essential.
Purpose of the Study:
- To evaluate the tuberculosis burden among refugees from Ukraine in European countries.
- To survey and analyze the TB screening policies implemented for these refugees.
- To identify disparities in TB notification rates based on screening strategies.
Main Methods:
- A survey was conducted across 30 EU/EEA and 13 other European countries.
- Data collected included migrant population figures, TB notifications by country of birth (Ukraine), and refugee screening policies.
- Analysis compared TB notification rates across countries with different screening approaches.
Main Results:
- In 2022, 6.9 million migrants and refugees from Ukraine resided in responding countries.
- TB notification rates were 12.8/100,000 in 2022, with 26% having multidrug-resistant/rifampicin-resistant TB (MDR/RR-TB).
- Countries with screening policies reported higher TB rates (14.7–16.9/100,000) than those without (7.2/100,000).
Conclusions:
- TB rates in refugees from Ukraine were lower than anticipated but higher where screening was recommended.
- The findings highlight the necessity for comprehensive TB health services for Ukrainian refugees.
- Tailored diagnosis and treatment, particularly for MDR/RR-TB, are critical for this population.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis I
231
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
231
Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis III
321
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
321
Pulmonary Tuberculosis V
177
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
Pulmonary Tuberculosis II
215
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
215

